Im just saying this so that we dont write off these other benefits aside from increased weight loss as insignificant
These findings represent an early view of patients receiving prescriptions or prescription fills of oral semaglutide for obesity
This one-page guide, developed by Heidi Diez, PharmD (first author), Jonathan Gabison, MD (co-first author), Lauren Oshman, MD, MPH, FAACP provides dosing and titration guidelines for switching between GLP-1 RA/GIPs during the national shortage in the United States, as well as functional tips for navigating medication shortages.
Ghrelin a new gastroprotective factor in gastric mucosa
The July 2026 advisory committee votes were meaningful, but they were not the final step